Advancements in Transdermal Drug Delivery
Advancements in Transdermal Drug Delivery is a research topic within Pharmaceutical Science. Science Explorer counts 25k research works in it since 1950. 22.1% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on innovations in transdermal drug delivery systems, including the use of solid lipid nanoparticles, microneedles, skin penetration enhancers, nanostructured lipid carriers, and microemulsion-based drug delivery. It explores advancements in overcoming the skin's barrier function and enhancing skin permeation for effective drug delivery.
- Solid Lipid Nanoparticles
- Microneedles
- Skin Penetration Enhancers
- Nanostructured Lipid Carriers
- Transdermal Drug Delivery
- Skin Barrier Function
- Microemulsion-based Drug Delivery
- Iontophoretic Drug Delivery
- Skin Permeation Enhancement
- Stratum Corneum
- Research works
- 25k fractional, since 1950
- In the world top 10%
- 5.5k per year above
- Top-10% rate
- 22.1% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +38% the tick is no change
Which countries lead Advancements in Transdermal Drug Delivery research?
By volume, India and China publish the most (1.1k and 975 works in 2022–2025).
By volume, 2022–2025
- 1 India 1.1k works
- 2 China 975 works
- 3 United States 514 works
- 4 Iran 194 works
- 5 South Korea 189 works
- 6 United Kingdom 175 works
- 7 Japan 166 works
- 8 Egypt 163 works
- 9 Brazil 144 works
- 10 Saudi Arabia 125 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Advancements in Transdermal Drug Delivery research?
By volume in 2022–2025, Hindu College of Pharmacy publishes the most Advancements in Transdermal Drug Delivery research, followed by Shenyang Pharmaceutical University and King Saud University.
By volume, 2022–2025
- 1 Hindu College of PharmacyIndia 38 works
- 2 Shenyang Pharmaceutical UniversityChina 28 works
- 3 King Saud UniversitySaudi Arabia 28 works
- 4 Queen's University BelfastUnited Kingdom 27 works
- 5 Cairo UniversityEgypt 24 works
- 6 Narsee Monjee Institute of Management StudiesIndia 23 works
- 7 Hasanuddin UniversityIndonesia 19 works
- 8 Shri Vile Parle Kelavani MandalIndia 19 works
- 9 Jamia HamdardIndia 18 works
- 10 Sichuan UniversityChina 17 works
Who are the leading researchers in Advancements in Transdermal Drug Delivery?
The most-cited researchers publishing on Advancements in Transdermal Drug Delivery include Róbert Langer and David Julian McClements.
- 1 Róbert Langer United States 4.2k citations
- 2 David Julian McClements United States 4.1k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Advancements in Transdermal Drug Delivery research done?
The largest centres of Advancements in Transdermal Drug Delivery research in 2022–2025 are Beijing (China), Seoul (South Korea), Shanghai (China) and Mumbai (India). Among places with at least 20 works in it, it is an unusually large share of all research in Sonīpat.
Largest cities, 2022–2025
Where it is the local speciality
- SonīpatIN · 40.6 works18×
Location quotient: how much more of its research is in Advancements in Transdermal Drug Delivery than the world average.
Where is the best place to study Advancements in Transdermal Drug Delivery?
Among universities, judged by research, Queen's University Belfast, Prince Sattam Bin Abdulaziz University and Jamia Hamdard score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Queen's University BelfastUnited Kingdom | 77.9 | 45.3% | 15.7× | 27 | +77.9% |
| 2 | Prince Sattam Bin Abdulaziz UniversitySaudi Arabia | 64.0 | 34.7% | 9.6× | 14 | — |
| 3 | Jamia HamdardIndia | 63.0 | 40.2% | 36.7× | 18 | +2.7% |
| 4 | Shenyang Pharmaceutical UniversityChina | 62.2 | 31.2% | 40.3× | 28 | +26.9% |
| 5 | Birla Institute of Technology and Science, PilaniIndia | 59.6 | 47.2% | 7.2× | 8 | +339.9% |
| 6 | China Pharmaceutical UniversityChina | 57.6 | 46.5% | 10.9× | 12 | -26.2% |
| 7 | Hindu College of PharmacyIndia | 56.1 | 3.9% | 67.6× | 38 | +104.1% |
| 8 | Delhi Pharmaceutical Science and Research UniversityIndia | 55.7 | 33.7% | 52.6× | 9 | +113.4% |
| 9 | Manipal Academy of Higher EducationIndia | 55.0 | 30.4% | 5.9× | 16 | +287.6% |
| 10 | King Saud UniversitySaudi Arabia | 52.3 | 25.2% | 5.6× | 28 | -6.7% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Advancements in Transdermal Drug Delivery research growing?
Output in 2018–2022 was 38% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Advancements in Transdermal Drug Delivery.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.